Ceftriaxone, an FDA-approved cephalosporin antibiotic, suppresses lung cancer growth by targeting Aurora B.
Li X; Li H; Li S; Zhu F; Kim DJ; Xie H; Li Y; Nadas J; Oi N; Zykova TA; Yu DH; Lee MH; Kim MO; Wang L; Ma W; Lubet RA; Bode AM; Dong Z; Dong Z; Carcinogenesis, 2012, vol. 33, issue 12, p 2548, ISSN 14602180. ISBN 14602180.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef